BIOMAT Database Logo BIOMAT Database Logo

[Comparative in vitro activity of aminoglycosides and rifampicin upon bacteria from clinical specimens (author's transl)]. 1981

J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore

UI MeSH Term Description Entries
D010303 Paromomycin An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D012853 Sisomicin Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex (GENTAMICINS). Sisomycin,Sissomicin,4,5-Dehydrogentamicin,Antibiotic 6640,Extramycin,Pathomycin,Rickamicin,Sch-13475,Siseptin,Sisomicin Sulfate,Sisomicin Sulfate (2:5) Salt,Sizomycin,4,5 Dehydrogentamicin,Sch 13475,Sch13475
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
December 1980, Revista medica de Chile,
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America.
April 2009, Journal of chemotherapy (Florence, Italy),
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[Changes of antimicrobial susceptibility of anaerobic bacteria from clinical specimens (author's transl)].
December 1975, The Japanese journal of antibiotics,
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[Anaerobic bacteria isolated from urine specimens (author's transl)].
December 1978, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[Anaerobic bacteria in clinical specimens of a hospital laboratory (author's transl)].
May 1981, Wiener klinische Wochenschrift,
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
November 1977, Praxis und Klinik der Pneumologie,
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[In vitro activity of cefoperazone against recently isolated bacteria from clinical specimens].
January 1988, Giornale italiano di chemioterapia,
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[Antimycotic sensitivity of yeast from clinical specimens (author's transl)].
July 1978, Deutsche medizinische Wochenschrift (1946),
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
April 1978, La Nouvelle presse medicale,
J Silva, and N Herrera, and S Becerra, and M Jofré, and A Gutiérrez, and Hannelore
[Studies on acinetobacter anitratus isolated from clinical specimens.--I. Isolation from clinical specimens (author's transl)].
November 1975, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!